November 29, 2022
Export Controls Give ASML and the Netherlands an Opportunity to Lead by Example. Will They Take It?
ASML is Europe's most valuable tech company, but lately it finds itself caught in a conflict between its commercial profits and its commitment to human rights. ASML makes the complex machines required to construct advanced microchips, and it sells many of these machines to China, where they are used to make microchips for—among other things— weapons used by the Chinese military and surveillance systems used by the Chinese state.
If the Netherlands adopted the U.S. controls, ASML and ASMI could continue most of their sales to China.
Over the past few months, the United States has been ramping up its export controls to limit China's access to advanced microchips. After the latest round of U.S. controls fell into place in early October, much attention was paid to how they can limit China's development of military technologies, particularly nuclear weapons and hypersonic missiles. Less attention has focused on another key motivation for the controls: limiting China's extensive systemic human rights abuses.
Read the full article from RAND.
This commentary originally appeared on de Volkskrant on November 27, 2022.
More from CNAS
-
Biotech Matters: Public-Private Coordination of Biotechnology
An appreciation of biotechnology’s great opportunities is, for many commentators, intimately joined with regret about a disconnect between the U.S. government and the private ...
By Richard Danzig
-
$6.6 billion TSMC deal in Arizona the latest in the CHIPS Act’s rollout
“President Biden signed the CHIPS and Science Act just about 20 months ago, which in government time is yesterday. And they’ve hired 200 people,” said Vivek Chilukuri, a senio...
By Vivek Chilukuri
-
Response to NTIA Request for Comment: “Dual Use Foundation Artificial Intelligence Models with Widely Available Model Weights”
In February 2024, the Department of Commerce’s National Telecommunications and Information Administration (NTIA) issued a Request for Comment (RFC) on the implications of “ope...
By Caleb Withers
-
Biotech Matters: Great Data Competition and Interoperability with Allies and Partners
Understanding and strengthening America’s biotechnology leadership requires exploring the limits of existing data relevant to the U.S. bioeconomy so that policymakers and the ...
By Michelle Holko